A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration.
A major UK clinical trial carried out in collaboration with the University of Birmingham has shown how a new approach to reduce the use of mechanical ventilation can greatly improve outcomes for critically ill children.
A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
Surgical patients who have recently had COVID-19 are more likely to develop potentially fatal post-operative blood clots, a new global study reveals.
In research that provides a new perspective on how blood clotting works in infectious and inflammatory diseases, Birmingham scientists have described a potential new target and strategy for anti-thrombotic therapy.
A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
Experts within Birmingham Health Partners have significantly contributed to a new independent report calling on the UK Government to reform the regulation of medical devices.
Researchers from the University of Birmingham have confirmed the speed, accuracy and simplicity of a novel, highly sensitive testing method for COVID-19.
More than one in 10 COVID-19 patients in 314 UK hospitals caught the infection in hospital during the first wave of the pandemic, finds a new study carried out in collaboration with the University of Birmingham.
A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the deaths and intensive care admissions of BAME COVID-19 patients with pneumoni.
Dr Amy Naylor is a Senior Research Fellow and member of the Rheumatology Research Group within the Institute of Inflammation and Ageing.
Patients isolating before surgery - mainly to avoid COVID-19 and its complications – are at a 20% increased risk of developing post-operative lung complications compared with patients who do not isolate.